Prognostic Markers for a Better Follow-up in Head and Neck Cancer.

Prognostic Markers for a Better Follow-up in Head and Neck Cancer.

To identify tumor specific DNA mutations and aberrations and to follow these in blood over time to predict treatment response/survival and secondly to correlate presence of these markers in blood to pathological parameters (LVI, Pn, WPOI and margins), radiological findings and to tumor stage.

Inclusion Criteria:

• Patient diagnosed with head and neck cancer
• Treatment includes surgery
• Consent to participate

Exclusion Criteria:

• No consent
• Age below 18 years
• No surgery
• No tumor material to sample